NewzThe General Directorate of Medicines, Supplies and Drugs (Digemid) has ordered the immediate withdrawal and destruction of two medical products from the market. The regulatory action was taken after health authorities identified critical manufacturing and quality deficiencies that could pose significant risks to patient safety.
The official alert details specific batch numbers for the affected medical items, advising healthcare providers and the public to avoid their use. The measure aims to prevent potential adverse health complications resulting from the compromised products.
In-depth summary · AI, neutral